A method for assaying and treating alzheimer's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4412 (2006.01) A61P 25/28 (2006.01) G01N 33/566 (2006.01) G01N 33/573 (2006.01) C07K 14/705 (2006.01)

Patent

CA 2123211

The present invention relates to a method of assaying for Alzheimer's disease in a human by determining the relative abundance of one or more forms of amyloid precursor protein (APP) or the enzyme responsible for said forms in circulatory fluid and to a method for treating the disease by modulating divalent cation, trivalent cation and/or heparin interaction with APP.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A method for assaying and treating alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A method for assaying and treating alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method for assaying and treating alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1670397

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.